Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2162 (LINC02162)

Target
LINC02162
Molecular classification
Long intergenic non-coding RNA (lincRNA), Long non-coding RNA (lncRNA), Non-coding RNA
01

Overview

Long intergenic non-protein coding RNA 2162 (LINC02162) is a gene locus that encodes a long intergenic non-coding RNA. lincRNAs are defined as RNA transcripts longer than 200 nucleotides that do not overlap with known protein-coding genes. These molecules are transcribed but are not translated into proteins and often regulate gene expression at the transcriptional or post-transcriptional level. While lincRNAs are increasingly recognized for their importance in diverse biological processes, including chromatin regulation, transcriptional modulation, and possibly disease processes, no biological function, disease relevance, or therapeutic targeting is known for LINC02162 specifically at this time[1][3][5].

Other names
LINC02162long intergenic non-protein coding RNA 2162
02

Biological functions

Specific biological function for LINC02162 is currently unknown.LincRNAs, as a class, are involved in transcriptional regulation.LincRNAs, as a class, are involved in chromatin remodeling.LincRNAs, as a class, are involved in regulation of neighboring gene expression.LincRNAs, as a class, often exhibit high tissue specificity.LincRNAs, as a class, can act as scaffolds for protein complexes involved in gene regulation.
03

Disease associations

No specific disease role has been identified for LINC02162.LincRNAs, as a class, have been implicated in various diseases, such as cancers.No association with cancer, inflammation, neurodegenerative disease, cardiovascular disease, or infection has been found for LINC02162 itself.

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2162 (LINC02162).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2162 (LINC02162).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call